Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.seminoncol.2014.09.013 http://scihub22266oqcxt.onion/10.1053/j.seminoncol.2014.09.013 C4270009!4270009!25499642     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Oncol 2014 ; 41 (6): 848-59 Nephropedia Template TP {{tp|p=25499642|t=2014. Altering the Response to Radiation: Sensitizers and Protectors |pdf=|usr=}}{{25499642}} gab.com Text Altering the Response to Radiation: Sensitizers and Protectors JO: Semin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=25499642 #FOAvip A number of agents are used clinically to enhance the efficacy of radiotherapy today, many of which are cytotoxic chemotherapies. Agents that enhance radiation induced tumor cell killing or protect normal tissues from the deleterious effects of ionizing radiation are collectively termed radiation modifiers. A significant effort in radiobiological research is geared towards describing and testing radiation modifiers with the intent of enhancing the therapeutic effects of radiation while minimizing normal tissue toxicity. In this review, we discuss the characteristics of these agents, the testing required to translate these agents into clinical trials, and highlight some challenges in these efforts. Twit Text FOAVip Altering the Response to Radiation: Sensitizers and Protectors ????Semin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=25499642 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25499642 #FOAvip English Wikipedia <ref>{{Cite pmid|25499642}}</ref> Altering the Response to Radiation: Sensitizers and Protectors #MMPMID25499642 Citrin DE; Mitchell JB Semin Oncol 2014[Dec]; 41 (6): 848-59 PMID25499642show ga A number of agents are used clinically to enhance the efficacy of radiotherapy today, many of which are cytotoxic chemotherapies. Agents that enhance radiation induced tumor cell killing or protect normal tissues from the deleterious effects of ionizing radiation are collectively termed radiation modifiers. A significant effort in radiobiological research is geared towards describing and testing radiation modifiers with the intent of enhancing the therapeutic effects of radiation while minimizing normal tissue toxicity. In this review, we discuss the characteristics of these agents, the testing required to translate these agents into clinical trials, and highlight some challenges in these efforts. äAltering the Response to Radiation: Sensitizers and Protectors (epmc).pdf DeepDyve Pubget Overpricing